Ysse Technologies
Financials
Estimates*
USD | 2021 |
---|---|
Revenues | <1m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Spinout | ||
$225k | Grant | ||
* | $230k | Grant | |
$3.3m | Seed | ||
$750k | Grant | ||
$750k | Grant | ||
$750k | Grant | ||
N/A | N/A | Series A | |
N/A | N/A | Series A | |
Total Funding | AUD9.3m |
Related Content
Recent News about Ysse Technologies
EditYesse Technologies, formerly known as MouSensor, is a pioneering company specializing in the development of advanced biosensors designed to detect and analyze odors. The company's core technology, often referred to as 'Nose-on-a-Chip,' integrates biological and electronic components to create highly sensitive and specific odor detection systems. These biosensors have significant applications in medical diagnostics, particularly in identifying biomarkers for diseases such as Parkinson's, as well as in environmental monitoring to detect pollutants and hazardous substances.
Yesse Technologies operates in the biotechnology and healthcare markets, serving clients that range from medical research institutions to environmental agencies. The business model is primarily based on research and development grants, strategic partnerships, and commercialization of its proprietary technology. The company generates revenue through grants from organizations such as the National Science Foundation and the Michael J. Fox Foundation, as well as through collaborations with industry partners and potential future sales of its biosensor products.
The company is supported by a multidisciplinary team of scientists, engineers, and entrepreneurs, and is backed by smart venture capitalists and experienced advisors. Yesse Technologies has received significant funding and recognition, including multiple NSF SBIR grants and awards from the Michael J. Fox Foundation, which underscores its innovative approach and potential impact in the field of odor detection and analysis.
Keywords: biosensors, odor detection, medical diagnostics, environmental monitoring, Parkinson's disease, biotechnology, healthcare, Nose-on-a-Chip, research grants, innovation.